New achievement with 3D-printing could have applications in pharmaceutical industry

NewsGuard 100/100 Score

University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilized gold with biodegradable and biocompatible systems that have been obtained with 3D-printng techniques. The image chosen for this test was the logo of the University of Seville.

This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumor biomarkers. In recent years, additive manufacturing, also commonly known as 3D printing, has been recognized as the ideal technology for applications that require intricate geometries or personalization. Its manufacturing based on layers will reduce general small-batch manufacturing costs in comparison with traditional production methods. This has caught the attention of the pharmaceutical industry, which has seen a gateway to the total personalization of treatment in this technology.

The research was centered on the technique called inkjet printing. This offers advantages such as its high resolution and the possibility it offers of being able to print more than one material during the same printing process. Using this technique, the researchers have proposed the manufacturing of systems that could potentially be used as personalized biosensors based on the conductivity and biocompatibility of gold.

Currently, existing gold inks for Inkjet Printing are based in nanoparticles of this metal, but they are highly unstable, as they bind together easily and are difficult to print. For that reason, the development of stale gold inks that are easy to print with has been invaluable.

The team was led by Ana Alcudia Cruz, of the Department of Organic and Pharmaceutical Chemistry from the Pharmacy faculty at the University of Seville, in collaboration of the group led by Rafael Prado Gotor of the Department of Physical Chemistry, from the Chemistry Faculty at the University of Seville, and Ricky Wilman, from the University of Nottingham (United Kingdom). For the first time, it managed to use polymers (polyurethanes) with a comb structure, which they themselves developed, to generate tiny gold nanoparticles with extremely high stability that was tested over time.

To that end, various polymers were prepared from arabinose, a sugar that is easily acquired in nature and that gives the material developed total biocompatibility and biodegradability, so avoiding polluting residues generated by the traditional polymers that are oil-derived.

For the first time this type of polymer has been used for the preparation of gold nanoparticles. These nanoparticles, obtained from three different chemically functionalized polymers, proved to be sufficiently small (maximum 10nm) to be printed in Inkjet printing and were stable for a period of at least six months. Once the printability of each ink was tested, that which showed the best balance of properties was selected and used to print the logo of our university. In the image, obtained by TOF-SIMS, the gold can be observed (in yellow), which forms the outline of the logo, on a polymer background (in blue). This is the first image of gold nanoparticles stabilized with biodegradable and biocompatible systems that has been obtained with 3D-printng techniques.

Source:
Journal reference:

Begines, B., et al. (2019) Design of highly stabilized nanocomposite inks based on biodegradable polymer-matrix and gold nanoparticles for Inkjet Printing. Scientific Reports. doi.org/10.1038/s41598-019-52314-2.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breaking through new research barriers with iPSC technology